Defined outcome ETFs limit losses but cap some of the gains (1:30) - What Should Investors Think About The Recent Market Action? (7:00) - What Is The Biggest Risk To The Stock Market Right Now? (13:30) - What Is A Defined Income ETF? (17:20) - Allianz’s Suite of Buffered Outcome ETFs (27:10) - How Do These ETF’s Fit Into An Investors Portfolio? Podcast@Zacks.com

Should You Limit Losses with Buffered ETFs?

Join us every week to listen to Neena interview fellow ETF experts within their industries

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Business

Investing

Careers

Management & Marketing

Business News

Shopping

We discuss factors driving Japanese stocks higher. (1:15) - Japanese Stock Market Rally: The Psychological Effect  (8:05) - What Impact Did Corporate Governance And Foreign Investors Have On The Japanese Stock Market Rally? (15:15) - Will This Rally Continue and For How Long? (18:00) - What Are The Current Risks for The Japanese Market? (20:00) - WisdomTree Japanese ETF Suite: DXJ, DFJ, DXJS (25:20) - Episode Roundup: EWJ & FLJP Podcast@Zacks.com

Can the Record Rally in Japan ETFs Continue?

We discuss bond market opportunities amid ‘higher for longer’ interest rates (1:45) - What Should Investors Expect From Interest Rates For The Rest of 2024? (8:00) - Is Now The Time To Step Away From Cash And Invest Into Stocks and Bonds? (12:15) - Where Are The Investment Opportunities Within The Fixed Income Market? (20:10) - Should You Revaluate Your 60/40 Portfolio? (24:05) - What Is Driving The Flows Into Bond ETFs? (28:20) - BlackRock Flexible Income ETF: BINC (33:10) - Episode Roundup: HYDB, ISGB, STIP Podcast@Zacks.com

Fixed Income ETFs: Where Should You Invest Now?

We discuss attractive investment opportunities within the healthcare industry. (1:15) - Learning The Background of Tema ETFs (3:30) - What Are GLP-1 Drugs and How Do They Work? (9:45) - Who Will Be Leaders In Developing These New Drugs? (15:00) - What Are The Most Promising Weight-loss Drugs In Development Right Now? (21:10) - How Will Political Pressure To Reduce Prices Impact These Companies? (25:05) - Tema Obesity & Cardiometabolic ETF: HRTS (29:25) - Tema Oncology ETF: CANC (34:55) - Tema Neuroscience and Mental Health ETF: MNTL (39:30) - Tema American Reshoring ETF: RSHO Podcast@Zacks.com

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond

Should you combine the growth potential of Mag 7 with the stability of dividend growers? (1:00) - How Long Will The Magnificent 7 Stay On Top? (5:10) - Breaking Down The Earnings Reports For The Magnificent 7 (8:00) - Roundhill Magnificent Seven ETF: MAGS (13:25) - Will Dividend Investing Make A Comeback In 2024? (16:00) - Roundhill S&P; Dividend Monarchs ETF: KNGS (22:30) - Bitcoin Covered Call Strategy ETF: YBTC Podcast@Zacks.com

Can Dividend Kings Outperform the Magnificent 7 ETF?

Where can investors find attractive opportunities within the fixed income market? (1:00) - What Should Investors Know About BondBloxx? (5:15) - What Is Driving The Growth In Fixed Income Investing Right Now? (10:15) - What Are The Advantages of Investing In Bond ETFs? (14:00) - How Many Rate Cuts Should Investor Expect This Year? (16:50) - Overview of BondBloxx ETF Suite (20:10) - Episode Roundup: XHLF, XBB, XCCC Podcast@Zacks.com

Should You Limit Losses with Buffered ETFs?

Download our free app to listen on your phone